Researchers from Xencor Inc. described the preclinical characterization of XmAb-808.

5Chineo Medical Technology Co., Ltd., Beijing, China.

I-DXd targets B7-H3, a protein overexpressed on the surface of a wide variety of cancer cells that binds to the CD28 family of receptors, which includes PD-1, targeted by MSD's widely used ...

*Estimated payments are calculated by Cars.com and are for informational purposes only. We’ve estimated your taxes based on your provided ZIP code. These estimates do not include title ...

This study was supported by grants from Instituto de Salud Carlos III/FIS (PS09/00897, PI11/00556). E Ripoll received a fellowship from IDIBELL and Societat Catalana de Transplantament, and A ...

Creative Commons (CC): This is a Creative Commons license. Attribution (BY): Credit must be given to the creator. V-domain immunoglobulin suppressor of T cell activation (VISTA), an inhibitory immune ...

周一，Piper Sandler将Xencor, Inc. (NASDAQ:XNCR)的股票评级从中性上调至增持，同时将目标价从之前的$20.00上调至$30.00。这一调整反映了对公司将其XmAb技术扩展到自身免疫疾病领域的积极展望。

Dr M-L Hammarström, Department of Immunology, Umeå University, S-901 85 Umeå, Sweden. Email:Marie-Louise.Hammarstrom{at}climi.umu.se. BACKGROUND AND AIMS A histopathological feature considered ...